BECTON DICKINSON INFUSION THERAPY UK consistently demonstrates a payment trend significantly beyond standard 30-day terms, with an average of 49 days. A clear trajectory shows 58% of payments fall into the 31-60 day range, indicating a consistent expectation for delayed settlement rather than prompt payment.
The 35% late payment rate and 24% of payments exceeding 60 days introduce significant volatility and unpredictability into BECTON DICKINSON's payment behavior. This indicates that while many payments fall within a 31-60 day window, a substantial portion cannot be reliably forecasted, increasing cash flow risk.
Overall, suppliers should anticipate payment terms averaging 49 days, with a significant portion consistently extending beyond 30 days and 35% being late. It is recommended to factor in these extended payment cycles and consider risk mitigation strategies such as clearer payment milestones or factoring services to manage potential cash flow impacts.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2025 - 30 Sept 2025 | 28 Oct 2025 | 49 | 18% | 58% | 24% | 35% |
| 01 Oct 2024 - 31 Mar 2025 | 23 Apr 2025 | 50 | 25% | 23% | 52% | 57% |
| 01 Apr 2024 - 30 Sept 2024 | 28 Oct 2024 | 54 | 20% | 24% | 57% | 66% |
| 01 Oct 2023 - 31 Mar 2024 | 19 Apr 2024 | 55 | 24% | 26% | 51% | 61% |
| 01 Apr 2023 - 30 Sept 2023 | 18 Oct 2023 | 53 | 22% | 28% | 50% | 62% |
| 01 Oct 2022 - 31 Mar 2023 | 24 Apr 2023 | 53 | 24% | 25% | 51% | 64% |
| 01 Apr 2022 - 30 Sept 2022 | 08 Mar 2023 | 67 | 6% | 29% | 65% | 77% |
| 01 Oct 2021 - 31 Mar 2022 | 08 Mar 2023 | 65 | 6% | 32% | 62% | 77% |
| 01 Apr 2021 - 30 Sept 2021 | 07 Mar 2022 | 57 | 27% | 41% | 31% | 47% |
| 01 Oct 2020 - 31 Mar 2021 | 29 Apr 2021 | 58 | 24% | 43% | 34% | 47% |
| 01 Apr 2020 - 30 Sept 2020 | 29 Oct 2020 | 51 | 30% | 32% | 38% | 38% |
| 01 Oct 2019 - 31 Mar 2020 | 27 Apr 2020 | 50 | 43% | 46% | 11% | 15% |
| 01 Apr 2019 - 30 Sept 2019 | 31 Oct 2019 | 64 | 29% | 50% | 21% | 27% |
| 01 Apr 2018 - 30 Sept 2018 | 25 Oct 2018 | 70 | 26% | 51% | 23% | 33% |
| 01 Oct 2017 - 31 Mar 2018 | 08 May 2018 | 59 | 18% | 48% | 34% | 40% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
60 days from invoice receipt date.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Any dispute arising would be settled amicably and as promptly as possible by discussion with the supplier concerned. These are to be dealt with primarily by the company's shared service center and if necessary, escalated to local finance.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
BECTON DICKINSON INFUSION THERAPY UK is an active private unlimited company specialising in infusion therapy within the United Kingdom.
The company was incorporated on 26 July 1954 and holds company number 00536128. Its registered office is located in the South East of England at 1030 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire, England, RG41 5TS.
Companies specialising in infusion therapy in the UK market typically provide a range of medical devices and related solutions. This includes infusion pumps, intravenous catheters, administration sets, and other consumables essential for healthcare providers.